Regulation of HMGB1 release by inflammasomes.
Journal: 2013/September - Protein & Cell
ISSN: 1674-8018
Abstract:
High mobility group box 1 (HMGB1) is an evolutionarily conserved non-histone chromatin-binding protein. During infection or injury, activated immune cells and damaged cells release HMGB1 into the extracellular space, where HMGB1 functions as a proinflammatory mediator and contributes importantly to the pathogenesis of inflammatory diseases. Recent studies reveal that inflammasomes, intracellular protein complexes, critically regulate HMGB1 release from activated immune cells in response to a variety of exogenous and endogenous danger signals. Double stranded RNA dependent kinase (PKR), an intracellular danger-sensing molecule, physically interacts with inflammasome components and is important for inflammasome activation and HMGB1 release. Together, these studies not only unravel novel mechanisms of HMGB1 release during inflammation, but also provide potential therapeutic targets to treat HMGB1-related inflammatory diseases.
Relations:
Content
Citations
(55)
References
(33)
Grants
(40)
Chemicals
(3)
Organisms
(1)
Anatomy
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Protein Cell 4(3): 163-167

Regulation of HMGB1 release by inflammasomes

Abstract

High mobility group box 1 (HMGB1) is an evolutionarily conserved non-histone chromatin-binding protein. During infection or injury, activated immune cells and damaged cells release HMGB1 into the extracellular space, where HMGB1 functions as a proinflammatory mediator and contributes importantly to the pathogenesis of inflammatory diseases. Recent studies reveal that inflammasomes, intracellular protein complexes, critically regulate HMGB1 release from activated immune cells in response to a variety of exogenous and endogenous danger signals. Double stranded RNA dependent kinase (PKR), an intracellular danger-sensing molecule, physically interacts with inflammasome components and is important for inflammasome activation and HMGB1 release. Together, these studies not only unravel novel mechanisms of HMGB1 release during inflammation, but also provide potential therapeutic targets to treat HMGB1-related inflammatory diseases.

Keywords: HMGB1, inflammasome, PKR
Laboratory of Biomedical Science, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030 USA
The Elmezzi Graduate School of Molecular Medicine, North Shore-LIJ Health system, 350 Community Drive, Manhasset, NY 11030 USA
Department of Emergency Medicine, North Shore University Hospital, Manhasset, NY 11030 USA
Department of Women’s and Children’s Health, Karolinska Institutet, S-17677 Stockholm, Sweden
Kevin J. Tracey, Email: ude.shsn@yecartjk.
Corresponding author.
Received 2012 Nov 27; Accepted 2012 Dec 12.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.